Chimerix/ US16934W1062 /
2024-10-25 9:53:53 PM | Chg. 0.00 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.87USD | +0.39% | 6,636 Turnover: 5,803.01 |
-Bid Size: - | -Ask Size: - | 0.88 | 0.87 |
GlobeNewswire
08-13
Chimerix Reports Second Quarter 2024 Financial Results and Provides Operational Update
GlobeNewswire
08-06
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antivi...
GlobeNewswire
08-06
Chimerix to Report Second Quarter 2024 Financial Results and Provide an Operational Update on August...
GlobeNewswire
05-30
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
GlobeNewswire
05-01
Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update
GlobeNewswire
04-24
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, ...
GlobeNewswire
02-29
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
GlobeNewswire
02-22
Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Upd...
GlobeNewswire
2023-11-16
Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating an...
GlobeNewswire
2023-11-02
Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update
GlobeNewswire
2023-10-26
Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on Novembe...
GlobeNewswire
2023-08-16
Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC20...
GlobeNewswire
2022-03-01
Chimerix Reports Fourth Quarter and Year End 2021 Financial Results and Provides Operational Update
GlobeNewswire
2022-02-28
Chimerix to Present at Cowen and Company 42nd Annual Health Care Conference